Can I Take Mounjaro for 6 Months? (October 2026)

01 · The short answer

Can you take Mounjaro for 6 months? Yes, with prescriber reviews

Yes, you can take Mounjaro for 6 months. Mounjaro (tirzepatide) is a once-weekly injection licensed in the UK for weight management in adults and for type 2 diabetes.¹ It is not designed as a short burst. In the SURMOUNT-1 trial of 2,539 adults, results were measured at 72 weeks, so six months sits comfortably inside the period studied.²

There is no fixed six-month cut-off. Your prescriber reviews how you are responding, how you are tolerating each dose and whether continuing or stopping is right for you. Treatment is used alongside a reduced-calorie diet and increased physical activity, not instead of them.¹

If you are wondering whether a short course is a sensible plan, our guide on taking Mounjaro for six months only goes through the trade-offs, and how many months you should take Mounjaro covers the wider question.

02 · The timeline

What six months on Mounjaro looks like

If you step up after at least 4 weeks on each dose, the first four pens are 2.5mg, 5mg, 7.5mg and 10mg. Whether you go higher than 10mg depends on your response and tolerance, not on a timetable.

Our guides on what six months on Mounjaro involves and how much you can lose in 6 months add more detail.

03 · Cost and ordering

What six months of Mounjaro costs and how to order

Cost depends on which doses you use, because each pen is priced by strength. The Mounjaro pen starts at £169.99 per month for 2.5mg, with 5mg at £218.99, 7.5mg at £279.99 and 10mg at £290.99.

New customers save £40 on their first order with code FIRST40, at any dose. An automatic £25 reorder discount applies to every future order (code DOSE25). Your first 2.5mg pen costs £129.99 with the first-order code, against the standard price of £169.99.

For the longer view, a first year costs £2,711.88 if you stay on 5mg after your 2.5mg starting pen, up to £3,599.88 if you step up through every dose to 15mg, at standard prices before discounts. Maintenance at 7.5mg is £279.99 per month, at 10mg £290.99 and at 12.5mg £319.99. Across the UK pharmacies we track, Mounjaro pens ranged from £143.96 to £339.00 per month as of 10 October 2026.

We supply through official LillyDirect, direct from Eli Lilly's UK distribution, with genuine KwikPens and all six doses stocked. Delivery is free, next-day and tracked in temperature-controlled packaging, with same-day dispatch when ordered by 3pm. Monthly clinical reviews are included, and there is no subscription lock-in. You can see how that works in buying six months of Mounjaro.

How ordering works:

• Complete the free online consultation, a short health questionnaire with no charge and no obligation.
• A GPhC-registered prescriber reviews it. Payment is taken when you place the order; if the prescriber decides the treatment is not suitable, the order is refunded automatically in full.
• Our registered pharmacy dispenses, and your pen arrives next day with needles, a sharps bin and injection guidance.

04 · Results at six months

What results to expect by six months

Trial averages show weight loss builds gradually, so six months is part-way through the course, not the end of it. In SURMOUNT-1, people taking tirzepatide alongside diet and exercise lost on average 15% of body weight on 5mg, 19.5% on 10mg and 20.9% on 15mg over 72 weeks, against 3.1% with lifestyle changes alone.² Those are 72-week averages, not six-month figures, and individual results vary.

To put it in numbers: for someone starting at 100 kg, 15% is about 15 kg and 20.9% is about 21 kg over the full 72 weeks. At 72 weeks, 85% of participants on 5mg, 89% on 10mg and 91% on 15mg had lost at least 5% of their body weight.²

At this stage the pace matters more than any single result. Weight loss on Mounjaro is gradual by design, so think in months, not days, and judge progress by trend rather than individual weigh-ins. Slower early progress does not predict failure, because the dose you respond to may still be ahead of you.

05 · Reviews and the 5% check

How your prescriber reviews progress

If you have lost less than 5% of your starting weight after 6 months on the highest dose you can tolerate, your prescriber will discuss whether continuing or stopping is right for you.

That is a conversation, not an automatic cut-off. It looks at your dose, side effects, eating pattern and goals. A prescriber may also consider what else has changed, such as sleep, alcohol or new medicines.

Beyond the scales, trial participants also saw average improvements in waist size, blood pressure, cholesterol and blood-sugar measures, and most participants with prediabetes returned to normal blood-sugar levels.² These are trial-average secondary outcomes, not promises. They are why prescribers talk about weight management as health management.

If you want to see how others frame the first stretch, what to expect after one month shows the early picture, and the weight loss injections 6 months guide compares injections more broadly.

06 · Plateaus along the way

What if progress stalls before six months?

A plateau of a few weeks is normal and does not mean the medicine has stopped working. Weight loss on Mounjaro is not linear, and the body adapts to a lower weight.

Within the licence, the sensible responses are:

• Review food intake honestly, as portions drift back up.
• Protect protein and keep active.
• Check the basics: sleep and alcohol.
• Discuss with your prescriber whether a dose step-up is appropriate, if you are not yet at maximum.

A plateau is not a reason to double doses or add unlicensed products. If it is the first weeks that worry you, appetite change and early loss vary widely: some people notice them in week one, others feel little until a higher dose. Both are normal. Early loss includes water weight, and mild nausea, altered appetite and tiredness in the first days after each injection are the commonest early effects and usually settle.

07 · Pens: can one last longer?

Can you use one Mounjaro pen for longer than 4 weeks?

No. A pen is a four-week supply, one weekly dose at a time, and you should not try to stretch it to eight weeks or two months. A pen in use can be kept out of the fridge at a temperature not above 30°C for up to 30 days after first use, and must then be thrown away. Do not use a pen that has been above 30°C or frozen.¹³

Unopened pens belong in the fridge until first use and keep until the printed expiry date.¹³ If you are unsure about a pen's condition, check the leaflet and contact the pharmacy rather than guessing. Changing how a pen is used, such as extra doses or stretching, is outside the licence, and we do not advise it.

Six months of treatment therefore means a series of pens, each reviewed and re-ordered in turn, with the dose set by your prescriber.

08 · After six months

What happens if you stop at six months?

You can stop at six months, but talk to your prescriber first. Tirzepatide has a half-life of about five days, so after a final dose it takes roughly 4–5 weeks to clear the system. There is no way to speed this up, and nothing needs doing while it clears.¹

Stopping should always be planned with your prescriber, with diet and activity habits ready. In SURMOUNT-4, people who stopped tirzepatide after 36 weeks regained on average 14% of body weight over the following year, while those who continued lost a further 5.5% on average. Our guide on whether you can take a GLP-1 for only six months goes through that decision. Report any new symptoms to your prescriber, and you can also report suspected side effects through the Yellow Card scheme.¹⁹

09 · Eligibility and the NHS

Who can take it, and NHS access

Mounjaro is licensed for weight management in adults with a BMI of 30 or above, or a BMI between 27 and 30 with at least one weight-related condition. Examples are high blood pressure, high cholesterol, obstructive sleep apnoea, cardiovascular disease, prediabetes or type 2 diabetes. It must be used alongside a reduced-calorie diet and increased physical activity.¹ A prescriber will assess your BMI, medical history and current medicines first.

Mounjaro is available on the NHS, but access is being phased in over several years. NICE recommends it for adults with a BMI of at least 35 plus at least one weight-related condition. The NHS primary-care rollout began in June 2025 with the highest-need groups first, initially BMI 40+ with four or more qualifying conditions.⁴⁶ Full rollout is expected to take years, which is why many people who meet the licensed criteria choose regulated private treatment rather than waiting.

Compare options on our weight loss treatments page. Mounjaro is a prescription-only medicine supplied only after an online consultation reviewed by a GPhC-registered prescriber. Individual results vary, and this page is information, not a substitute for medical advice.